Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
ALEXION Pharmaceuticals Inc on Wednesday said it agreed to buy Synageva BioPharma Corp for US$8.4 billion, more than twice its market value, to expand its offering of potentially high-priced medicines for rare diseases.
Alexion's willingness to pay an eye-popping premium for...